18<scp>F</scp>‐fluorodeoxyglucose <scp>PET‐CT</scp>‐guided pelvic chemoradiation therapy using helical tomotherapy for locally advanced carcinoma cervix without para‐aortic nodal disease: Clinical and patient‐reported outcomes from a prospective phase 2 study
Rimpa Basu Achari(Tata Medical Center), Tapesh Bhattacharyya(Tata Medical Center), Moses Arunsingh(Tata Medical Center), Aditi Chandra, Jayanta Das(Tata Medical Center), Jaydip Bhaumik(Tata Medical Center), Kanishka Sarkar(Tata Medical Center), Anik Ghosh, Basumita Chakraborti, Indranil Mallick(Tata Medical Center), Santam Chakraborty(Tata Medical Center), Soumendranath Ray(Tata Medical Center), Anurupa Mahata(Tata Medical Center), Saugata Sen(University of Toronto), Sanjoy Chatterjee(Tata Medical Center), S. Mandal(Bose Institute)
Cited by 1
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19
|Science Immunology|2021|206
The RSNA Pulmonary Embolism CT Dataset
|Radiology Artificial Intelligence|2021|104
‘Plan of the day’ adaptive radiotherapy for bladder cancer using helical tomotherapy
|Radiotherapy and Oncology|2011|88